Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marco Barbieri, F. Loconsole, A. Migliore & S. Capri. (2020) A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting. Journal of Medical Economics 23:4, pages 362-370.
Read now
Read now
Hunar Abdulrahim, Hisham Sharlala & Adewale O. Adebajo. (2019) An evaluation of tofacitinib for the treatment of psoriatic arthritis. Expert Opinion on Pharmacotherapy 20:16, pages 1953-1960.
Read now
Read now
Katelyn R. Glines, Katherine M. Stiff, Megan Freeze, Abigail Cline, Lindsay C. Strowd & Steven R. Feldman. (2019) An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opinion on Pharmacotherapy 20:5, pages 621-629.
Read now
Read now
Luca Bianchi, Ester Del Duca, Marco Romanelli, Rosita Saraceno, Sergio Chimenti & Andrea Chiricozzi. (2016) Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis. Expert Opinion on Drug Metabolism & Toxicology 12:9, pages 1121-1128.
Read now
Read now
Andrea Chiricozzi, Dante Caposiena, Virginia Garofalo, Maria Vittoria Cannizzaro, Sergio Chimenti & Rosita Saraceno. (2016) A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast. Expert Review of Clinical Immunology 12:3, pages 237-249.
Read now
Read now
Articles from other publishers (29)
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, Piyong Sola & Emdormi Rymbai. (2023) Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential. Cellular and Molecular Neurobiology 43:6, pages 2713-2741.
Crossref
Crossref
Neelam PatelSunita ChaudharyAnkit Chaudhary. (2023) Formulation Development and Evaluation of Apremilast Nanoemulsion. Research Journal of Pharmacy and Technology, pages 2859-2866.
Crossref
Crossref
Annika Mohr, Manuela Besser, Sonja Broichhausen, Maximiliane Winter, Alexander D. Bungert, Benjamin Strücker, Mazen A. Juratli, Andreas Pascher & Felix Becker. (2023) The Influence of Apremilast-Induced Macrophage Polarization on Intestinal Wound Healing. Journal of Clinical Medicine 12:10, pages 3359.
Crossref
Crossref
Neelam Patel, Sunita Chaudhary & Ankit Chaudhary. (2023) Formulation Development and Evaluation of Apremilast Nanoemulgel for
Enhancing Permeability. Current Drug Therapy 18:2, pages 132-150.
Crossref
Crossref
Kentaro Nakamura, Yukiyasu Arakawa, Koji Masuda, Takahiro Arita, Norito Katoh & Jun Asai. (2022) Exacerbation of psoriatic arthritis due to topical imiquimod therapy. International Journal of Dermatology 62:3.
Crossref
Crossref
Yinsi Lin, Jianhui Su, Mingqiang Wang, Yanzhen Li, Zhongxiang Zhao & Zhanghua Sun. (2022) Hypericum sampsonii attenuates inflammation in mice with ulcerative colitis via regulation of PDE4/PKA/CREB signaling pathway. Journal of Ethnopharmacology 296, pages 115447.
Crossref
Crossref
Ingrid Allart-Simon, Aurélie Moniot, Nicolo Bisi, Miguel Ponce-Vargas, Sandra Audonnet, Marie Laronze-Cochard, Janos Sapi, Eric Hénon, Frédéric Velard & Stéphane Gérard. (2021) Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors. RSC Medicinal Chemistry 12:4, pages 584-592.
Crossref
Crossref
Paulo Sarango-Granda, Marcelle Silva-Abreu, Ana Calpena, Lyda Halbaut, María-José Fábrega, María Rodríguez-Lagunas, Natalia Díaz-Garrido, Josefa Badia & Lupe Espinoza. (2020) Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation. Pharmaceuticals 13:12, pages 484.
Crossref
Crossref
Maurizio Cutolo, Stefano Soldano, Paola Montagna, Giulia Martinelli, Samuele Tardito, Claudio Corallo, Nicola Giordano, Pierpaolo Tavilla, Emanuele Cozzani, Aurora Parodi, Alberto Sulli, Carmen Pizzorni, Massimo Patane, Vanessa Smith & Sabrina Paolino. (2020)
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts:
in vitro
study
. Rheumatology 59:12, pages 3927-3938.
Crossref
Crossref
Cervantes-Durán Claudia, Velázquez-Hernández María-Elena, Valentín-Escalera Josué, Bartolomé-Camacho María-Carmen, Rodríguez-Orozco Alain-Raimundo & García-Pérez Martha-Estrella. (2020) Small molecules under development for psoriasis: on the road to the individualized therapies. Archives of Dermatological Research 312:9, pages 611-627.
Crossref
Crossref
Christopher Ma, Robert Battat, Parambir S. Dulai, Claire E. Parker, William J. Sandborn, Brian G. Feagan & Vipul Jairath. (2019) Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs 79:12, pages 1321-1335.
Crossref
Crossref
Heng Li, Chen Fan, Chunlan Feng, Yanwei Wu, Huimin Lu, Peilan He, Xiaoqian Yang, Fenghua Zhu, Qing Qi, Yuanzhuo Gao, Jianping Zuo & Wei Tang. (2019) Inhibition of phosphodiesterase‐4 attenuates murine ulcerative colitis through interference with mucosal immunity. British Journal of Pharmacology.
Crossref
Crossref
Chang Huang, Qiu‐Ping Zhong, Lv Tang, Hai‐Tao Wang, Jiang‐Ping Xu & Zhong‐Zhen Zhou. (2018) Discovery of 2‐(3,4‐dialkoxyphenyl)‐2‐(substituted pyridazin‐3‐yl)acetonitriles as phosphodiesterase 4 inhibitors with anti‐neuroinflammation potential based on three‐dimensional quantitative structure–activity relationship study. Chemical Biology & Drug Design 93:4, pages 484-502.
Crossref
Crossref
Heng Li, Jianping Zuo & Wei Tang. (2018) Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases. Frontiers in Pharmacology 9.
Crossref
Crossref
E. Yu. Loginova & T. V. Korotaeva. (2018) Clinical experience with apremilast for psoriatic arthritis. Modern Rheumatology Journal 12:3, pages 103-108.
Crossref
Crossref
Xuemei Liu, Rui Chen, Guanghuai Zeng, Ying Gao, Xiuping Liu, Donglei Zhang, Pei Hu, Hongyun Wang & Ji Jiang. (2018) Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC–MS/MS and its application to a PK study. Bioanalysis 10:11, pages 863-875.
Crossref
Crossref
Chantal Barberot, Aurélie Moniot, Ingrid Allart-Simon, Laurette Malleret, Tatiana Yegorova, Marie Laronze-Cochard, Abderrazzaq Bentaher, Maurice Médebielle, Jean-Philippe Bouillon, Eric Hénon, Janos Sapi, Frédéric Velard & Stéphane Gérard. (2018) Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents. European Journal of Medicinal Chemistry 146, pages 139-146.
Crossref
Crossref
Gaopeng Song, Xiang Zhu, Junhua Li, Dekun Hu, Dongsheng Zhao, Yixian Liao, Juntong Lin, Lian-Hui Zhang & Zi-Ning Cui. (2017) Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors. Bioorganic & Medicinal Chemistry 25:20, pages 5709-5717.
Crossref
Crossref
Daniel Wendling & Clément Prati. (2017) Targeted synthetic disease-modifying antirheumatic drugs in spondyloarthritis. Immunotherapy 9:3, pages 221-223.
Crossref
Crossref
Zhong-Zhen Zhou, Yu-Fang Cheng, Zheng-Qiang Zou, Bing-Chen Ge, Hui Yu, Cang Huang, Hai-Tao Wang, Xue-Mei Yang & Jiang-Ping Xu. (2016)
Discovery of
N
-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses
. ACS Chemical Neuroscience 8:1, pages 135-146.
Crossref
Crossref
Shashikant B. Landge, Sunil B. Dahale, Sanjay A. Jadhav, Pavankumar V. Solanki, Saroj R. Bembalkar & Vijayavitthal T. Mathad. (2017) Development and Validation of Stability Indicating Rapid RP-LC Method for Determination of Process and Degradation Related Impurities of Apremilast, an Anti-Inflammatory Drug. American Journal of Analytical Chemistry 08:06, pages 380-394.
Crossref
Crossref
Zhong-Zhen Zhou, Bing-Chen Ge, Qiu-Ping Zhong, Chang Huang, Yu-Fang Cheng, Xue-Mei Yang, Hai-Tao Wang & Jiang-Ping Xu. (2016) Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings. European Journal of Medicinal Chemistry 124, pages 372-379.
Crossref
Crossref
Rachael C. Saporito & David J. Cohen. (2016) Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients. Case Reports in Dermatology 8:2, pages 179-184.
Crossref
Crossref
Peter H. Schafer, Francesca Truzzi, Anastasia Parton, Lei Wu, Jolanta Kosek, Ling-Hua Zhang, Gerald Horan, Annalisa Saltari, Marika Quadri, Roberta Lotti, Alessandra Marconi & Carlo Pincelli. (2016) Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex. Cellular Signalling 28:7, pages 753-763.
Crossref
Crossref
Kaihe Xiong, Xingling Ma, Na Cao, Lei Liu, Lili Sun, Qiaogen Zou & Ping Wei. (2016) Identification, characterization and HPLC quantification of impurities in apremilast. Analytical Methods 8:8, pages 1889-1897.
Crossref
Crossref
Amit Om, Dane Hill & Steven R. Feldman. 2016. Therapy for Severe Psoriasis. Therapy for Severe Psoriasis
75
82
.
Garry G. Graham & Kevin D. Pile. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases
1079
1084
.
Fabiola Atzeni, Ignazio F Masala, Laura Boccassini & Piercarlo Sarzi-Puttini. (2015) Early psoriatic arthritis: should we treat it in the same way as we treat rheumatoid arthritis?. International Journal of Clinical Rheumatology 10:6, pages 399-408.
Crossref
Crossref
Silvia Martina Ferrari, Ilaria Ruffilli, Michele Colaci, Alessandro Antonelli, Clodoveo Ferri & Poupak Fallahi. (2015) CXCL10 in psoriasis. Advances in Medical Sciences 60:2, pages 349-354.
Crossref
Crossref